Prothena Corporation plc (PRTA)
NASDAQ: PRTA · IEX Real-Time Price · USD
20.39
-0.09 (-0.44%)
At close: Jul 2, 2024, 4:00 PM
20.60
+0.21 (1.03%)
After-hours: Jul 2, 2024, 5:58 PM EDT
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $1.10 billion as of July 2, 2024. Its market cap has decreased by -69.26% in one year.
Market Cap
1.10B
Enterprise Value
561.04M
1-Year Change
-69.26%
Ranking
Category
Stock Price
$20.39
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $1.10B, an increase of 761.28%. That is a compound annual growth rate of 20.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 1.10B | -43.78% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Day One Biopharmaceuticals | 1.20B |
| Immatics | 1.20B |
| Spyre Therapeutics | 1.19B |
| Xencor | 1.17B |
| Verona Pharma | 1.12B |
| AtriCure | 1.10B |
| Enliven Therapeutics | 1.10B |
| 4D Molecular Therapeutics | 1.09B |